This inventor holds 1 USPTO granted patent. Top assignee: Jiangnan University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Lu Xu - Innovator in Biological Medicine
Introduction
Lu Xu is a prominent inventor based in Wuxi, China. He has made significant contributions to the field of biological medicine, particularly in the treatment of castration-resistant prostate cancer. His innovative approach combines natural compounds with established therapies to enhance treatment efficacy.
Latest Patents
Lu Xu holds a patent titled "Application of Stachyose in Preparation of Drug for Treating Castration-Resistant Prostate Cancer." This patent discloses a novel application of Stachyose, a natural compound, in conjunction with an androgen receptor antagonist. The research presents a new strategy for treating castration-resistant prostate cancer (CRPC) and includes multi-angle and multi-level verification studies. The drug composition significantly improves the effectiveness of Enzalutamide, a common treatment for CRPC, thereby offering important clinical therapeutic significance.
Career Highlights
Lu Xu is affiliated with Jiangnan University, where he conducts research and develops innovative medical solutions. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from advanced stages of cancer.
Collaborations
Lu Xu collaborates with notable colleagues, including Rong Wang and Yongquan Chen, who contribute to his research efforts and enhance the scope of his projects.
Conclusion
Lu Xu's contributions to biological medicine, particularly through his patent on Stachyose, highlight his role as an innovator in the fight against castration-resistant prostate cancer. His work not only advances medical science but also offers hope for improved patient outcomes.